Latest news

Covid 19 Top 10 News Updates for Bangalore – 19 November 2021

  • State reports 313 new COVID-19 cases, four deaths
    Karnataka on Thursday reported 313 new cases of COVID-19, taking the total to 29,92,897. Bengaluru Urban reported 179 cases and two deaths. With four deaths, the toll rose to 38,165.
    Read more 
  • II PU mid-term exam dates revised
    Under pressure from the parents and student bodies, the department of pre-university education on Thursday revised the dates of mid-term examinations for second PUC students.
    Read more 
  • AI played effective role in healthcare delivery during COVID-19 crisis
    Artificial Intelligence (AI) has ensured effective and efficient delivery of services, especially in healthcare, during the COVID-19 crisis, said K. Ananth Krishnan, Executive VP & Chief Technology Officer, Tata Consultancy Services.
    Read more 
  • State lax in probing deaths following vaccinations
    Karnataka has scored poorly in investigating deaths following Covid immunisation. The Centre’s data shows that more than 30% of severe adverse events following immunisation (AEFI) cases in the state resulted in deaths.
    Read more 
  • Over 128 crore Covid-19 vaccine doses provided to states, UTs so far
    The Ministry of Health and Family Welfare on Thursday said that more than 128 crore (1,28,49,86,340) Covid-19 vaccine doses have been provided to states and union territories so far through free of cost channel and through direct state procurement category.
    Read more 
  • India may start vaccinating children against COVID-19 in six weeks: Report
    India is likely to start vaccinating children against COVID-19 in the next six weeks. Vaccination will start with approved vaccines and children with co-morbidities will be vaccinated in the first phase, followed by all children in the second phase.
    Read more 
  • 100 million have or had long Covid-19, estimates study
    More than 40% of Covid-19 survivors worldwide have had lingering after-effects of the illness, researchers from the University of Michigan estimate, based on their review of 40 earlier studies from 17 countries that looked at patients’ experiences with so-called long Covid, defined as new or persistent symptoms at four or more weeks after infection.
    Read more 
  • Delta subvariant less likely to cause symptoms: UK study
    A subvariant of Delta that is growing in Britain is less likely to lead to symptomatic Covid-19 infection, a coronavirus prevalence survey found, adding that overall cases had dropped from a peak in October.
    Read more 
  • In 5th wave, France sees 20k cases/day for 1st time since Aug
    France registered more than 20,000 new confirmed cases on Wednesday for the first time since August 25 as the fifth wave of the epidemic picked up speed. The health ministry reported 20,294 new cases, taking the total to 7.33 million and the seven-day moving average of new cases to above 12,400.
    Read more 
  • Pfizer, US ink $5bn deal for Covid pills
    The US will pay Pfizer $5.29 billion for 10 million treatment courses of its potential Covid treatment if regulators authorise it, the nation’s largest purchase deal yet for a coronavirus therapy. Pfizer asked the FDA on Tuesday to authorise emergency use of the experimental pill, which has been shown to significantly cut the rate of virus hospitalisations and deaths.
    Read more 

 

Related Articles